Pharmafile Logo

Glaucoma in perspective

- PMLiVE

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

SWITCHED ONcology Patient Experience Focus Group Full Discussion

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. In...

Havas Lynx

SWITCHED ONcology Patient Experience Focus Group Highlights

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. "We...

Havas Lynx

- PMLiVE

CTI slumps as Servier-partnered lymphoma drug fails

After major setback CTI, has promising myelofibrosis candidate to fall back on

Creativity has lost its worth

Creativity has lost its worth, and sadly it is undermining effectiveness

Page & Page Health

Healthcare Comms appointments

Cuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWAWorldHealth London sees Andy Hayley and Dick Dunford return

- PMLiVE

NHS England says yes to Roche’s Hemlibra

But stalls on funding for Actelion's Uptravi

- PMLiVE

Communiqué: big wins for obesity and sugar tax campaigners

More highlights from healthcare communications awards

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links